Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa R Tannock

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 20, 2007
Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetesPatricia Wilson, Katherine Drennon, Lisa R Tannock
Current Opinion in Lipidology|July 8, 2011
Serum amyloid A in atherosclerosisVictoria L King, Joel Thompson, Lisa R Tannock
Biomolecules|December 24, 2021
Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular DiseasesPreetha Shridas, Avery C Patrick, Lisa R Tannock
Diabetes Research and Clinical Practice|November 18, 2011
Durability of glycemic control using U-500 insulinAlexandria M Dailey, Jennifer A Gibert, Lisa R Tannock
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 22, 2018
INSULIN DOSE REDUCTIONS IN THE INPATIENT SETTING: HOW MUCH IS ENOUGH?Stephanie M Keca, John T Emmons, Lisa R Tannock
Archives of Physiology and Biochemistry|May 20, 2008
Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATPPeter J Little, Katherine D Drennon, Lisa R Tannock
Postgraduate Medicine|January 29, 2010
Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical managementAparna Brown, Megha Desai, Deepa Taneja, et al.
Reviews in Endocrine & Metabolic Disorders|December 22, 2016
Dyslipidemia in patients with chronic kidney diseaseMatthew R Hager, Archana D Narla, Lisa R Tannock
Clinical Trials (London, England)|July 2, 2019
Creation of an institutional semi-independent data monitoring committeeLisa R Tannock, Marietta Barton-Baxter, William W Stoops
Diabetes Research and Clinical Practice|March 16, 2010
Clinical efficacy and patient satisfaction with U-500 insulin useAlexandria M Dailey, Sarah Williams, Deepa Taneja, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 20, 2007
Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetesPatricia Wilson, Katherine Drennon, Lisa R Tannock
Current Opinion in Lipidology|July 8, 2011
Serum amyloid A in atherosclerosisVictoria L King, Joel Thompson, Lisa R Tannock
Biomolecules|December 24, 2021
Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular DiseasesPreetha Shridas, Avery C Patrick, Lisa R Tannock
Diabetes Research and Clinical Practice|November 18, 2011
Durability of glycemic control using U-500 insulinAlexandria M Dailey, Jennifer A Gibert, Lisa R Tannock
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 22, 2018
INSULIN DOSE REDUCTIONS IN THE INPATIENT SETTING: HOW MUCH IS ENOUGH?Stephanie M Keca, John T Emmons, Lisa R Tannock
Archives of Physiology and Biochemistry|May 20, 2008
Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATPPeter J Little, Katherine D Drennon, Lisa R Tannock
Postgraduate Medicine|January 29, 2010
Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical managementAparna Brown, Megha Desai, Deepa Taneja, et al.
Reviews in Endocrine & Metabolic Disorders|December 22, 2016
Dyslipidemia in patients with chronic kidney diseaseMatthew R Hager, Archana D Narla, Lisa R Tannock
Clinical Trials (London, England)|July 2, 2019
Creation of an institutional semi-independent data monitoring committeeLisa R Tannock, Marietta Barton-Baxter, William W Stoops
Diabetes Research and Clinical Practice|March 16, 2010
Clinical efficacy and patient satisfaction with U-500 insulin useAlexandria M Dailey, Sarah Williams, Deepa Taneja, et al.
Pageof 7